Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Triton X-114 Phase Separation based Endotoxin Removal Service

Introduction Mechanism Key Features Our Services Contact Us FAQs

Introduction

Endotoxins are primary components of the outer membrane of gram-negative bacteria like E. coli. During recombinant protein expression, these molecules are released in massive quantities, particularly when proteins are isolated from the soluble cytoplasmic fraction. The presence of even nanogram quantities can compromise experimental results by inducing systemic inflammation or septic shock in mammalian hosts.

Triton X-114 phase separation is a common method to remove endotoxins. It is a specialized detergent-based technique designed to exploit the physical properties of non-ionic surfactants to isolate these contaminants. Unlike standard chromatography, which may suffer from non-specific binding, this method provides a gentle yet highly efficient alternative for achieving the rigorous purity standards required for modern biopharmaceuticals.

Endotoxin Removal with Triton X-114 (OA Literature)Fig.1 Endotoxin removal from human Ferritin with Triton X-114.1

Mechanism of Endotoxin Removal by Triton X-114

The effectiveness of Triton X-114 in removing endotoxins from protein solutions is rooted in its unique thermodynamic behavior and its ability to act as a physical partition between hydrophilic and hydrophobic molecules. This process is highly efficient because it utilizes the physical characteristics of the detergent to sequester contaminants without requiring complex chemical reactions.

Micellar Dissociation

  • At 4℃, Triton X-114 micelles to bind to the hydrophobic Lipid A moiety of the endotoxin, dissociating it from the target protein.

Phase Partitioning

  • At 37℃, the detergent molecules aggregate, and the solution separates into two distinct phases.

Physical Sequestration

  • The hydrophobic endotoxins remain in bottom oily detergent-rich phase and the purified recombinant proteins remain in the upper aqueous phase.

Key Features of Endotoxin Removal by Triton X-114

Triton X-114 phase separation is a superior technological balance between high-potency decontamination and the preservation of protein integrity. This process is governed by predictable thermodynamic principles that offer several distinct advantages for biopharmaceutical applications.

High Efficiency

A single cycle can achieve a 1000-fold reduction in endotoxin levels, with triple-extraction protocols reaching high removal rate (>99%).

Superior Protein Recovery

This method typically yields recovery rates exceeding 90-95% per cycle, significantly outperforming affinity-based resins.

Structural Preservation

The process occurs at physiological temperatures and utilizes gentle surfactants, which preserves the quaternary structure and biological activity of complex molecules.

Scalability

The procedure is highly versatile, effectively processing volumes ranging from 1 mL to 500 mL without loss of performance.

Our Endotoxin Removal Service by Triton X-114 Phase Separation

At Creative Biolabs, we provide a specialized endotoxin removal service that utilizes refined Triton X-114 to achieve ultra-pure protein yields. While standard laboratory protocols often leave behind residual detergent (~0.018%) that can be toxic to sensitive cell lines or interfere with results, our proprietary process ensures your protein is both endotoxin-free and assay-ready for critical clinical and research applications.

Massive Reduction

We consistently achieve over 99% endotoxin reduction through our validated triple-extraction protocols.

High Protein Recovery

Our methods prioritize the preservation of your valuable material, targeting recovery rates greater than 90%.

Clinical-Grade Thresholds

We routinely lower endotoxin levels to <0.1 EU/mg, meeting the most rigorous safety standards for in vivo and cell-based studies.

  • Homogenization
    Triton X-114 is added to the protein preparation and incubated at 4℃.
  • Thermal Phase Induction
    The sample is transferred to a precision-controlled 37°C water bath. This triggers the phase transition.
  • Aqueous Recovery
    The sample is centrifuged to fully separate the two phases.
  • Iterative Extraction
    The aqueous phase is subjected to 2-3 cycles of phase separation.
  • Residual Detergent Polishing
    Residual detergent is removed from the aqueous phase.
  • Final Validation
    Perform LAL testing to confirm endotoxin levels and other assays to verify protein integrity and activity.

Workflow of Our Endotoxin Removal Service by Triton X-114 Phase Separation.

Contact Us

Creative Biolabs provides an industry-leading endotoxin removal service utilizing Triton X-114 phase separation. We combine 20 years of technical expertise with advanced detergent-polishing protocols to deliver proteins with high endotoxin reduction and high recovery. Contact us for more information and to discuss your project.

FAQs

How do you ensure the detergent doesn't interfere with my cell assays?

We implement a secondary polishing step using adsorption beads or size-exclusion chromatography to reduce residual Triton X-114 to levels below 0.005%, which is safe for sensitive cell lines like macrophages.

What is the lowest level of endotoxin you can achieve?

We routinely achieve levels below 1 EU/mg, and for specific high-sensitivity requirements, we can reach < 0.1 EU/mg through extended extraction cycles.

Can this method handle proteins that bind endotoxin tightly?

Yes. This is a core advantage of Triton X-114. The micellar structure is more effective at competing for the hydrophobic lipid A than affinity resins, making it the preferred choice for sticky proteins.

How much protein will I lose during the process?

Our protocols are optimized for >90% recovery. We provide a full recovery analysis in your final report.

Reference

  1. Silva, Filippo, et al. "Combined method to remove endotoxins from protein nanocages for drug delivery applications: the case of human ferritin." Pharmaceutics 13.2 (2021): 229. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/pharmaceutics13020229
Contact Us
© 2026 Creative Biolabs. All rights reserved.